F
Frederick L. Ferris
Researcher at National Institutes of Health
Publications - 250
Citations - 43347
Frederick L. Ferris is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Diabetic retinopathy & Macular degeneration. The author has an hindex of 87, co-authored 246 publications receiving 38343 citations. Previous affiliations of Frederick L. Ferris include American Medical Association & Johns Hopkins University.
Papers
More filters
Journal ArticleDOI
Complement Factor H Polymorphism in Age-Related Macular Degeneration
Robert J. Klein,Caroline J. Zeiss,Emily Y. Chew,Jen-yue Tsai,Richard S. Sackler,Chad Haynes,A. K. Henning,John Paul SanGiovanni,Shrikant Mane,Susan T. Mayne,Michael B. Bracken,Frederick L. Ferris,Jurg Ott,Colin J. Barnstable,Josephine Hoh +14 more
TL;DR: A genome-wide screen for polymorphisms associated with age-related macular degeneration revealed a polymorphism in linkage disequilibrium with the risk allele representing a tyrosine-histidine change at amino acid 402 in the complement factor H gene.
Journal ArticleDOI
Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales
Charles P. Wilkinson,Frederick L. Ferris,Ronald Klein,Paul P. Lee,Carl-David Agardh,Matthew D. Davis,Diana G. Dills,Anselm Kampik,R Pararajasegaram,T Juan Verdaguer +9 more
TL;DR: There seems to be a genuine need for consistent international clinical classification systems for diabetic retinopathy and diabetic macular edema that are supported with solid evidence.
Journal ArticleDOI
New visual acuity charts for clinical research
TL;DR: Three new visual acuity charts facilitate quantitative use ofVisual acuity test results by providing high-contrast lettering on washable white polystyrene on which to test right and left eyes.
Journal ArticleDOI
Complement factor H polymorphism in age-related macular degeneration
Robert J. Klein,C. Zeiss,Emily Y. Chew,J.Y. Tsai,Richard S. Sackler,Chad Haynes,A. K. Henning,John Paul SanGiovanni,S.M. Manne,S.T. Mayne,Michael B. Bracken,Frederick L. Ferris,Jurg Ott,Colin J. Barnstable,Josephine Hoh +14 more
TL;DR: A genome-wide screen for polymorphisms associated with age-related macular degeneration revealed a polymorphism in linkage disequilibrium with the risk allele representing a tyrosine-histidine change at amino acid 402 in the complement factor H gene.
Journal ArticleDOI
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.
Daniel F. Martin,Maureen G. Maguire,Stuart L. Fine,Gui-Shuang Ying,Glenn J. Jaffe,Juan E. Grunwald,Cynthia A. Toth,Maryann Redford,Frederick L. Ferris +8 more
TL;DR: Ranibizumab and bevacizumAB had similar effects on visual acuity over a 2-year period and switching from monthly to as-needed treatment resulted in greater mean decrease in vision during year 2.